Similarly, pooled data in a meta-analysis supported that recessive genetic model (GG vs. GC+CC) of IL-6 -174 G>C polymorphism is significantly associated with increased survival of women with ovarian cancer, peritoneal cancer and other malignancies. This evidence concerns the gene IL6 and ovarian cancer.